Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK InhibitorsHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosisRecruitingPhase 1 / Phase 22026-06-23NCT06887803

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
iOnctura6

12 results · Page 1 of 1

Swipe the table sideways for more columns.